Olix Pharmaceuticalsincis A Clinical Stage Pharmaceutical Company Based In Suwon Sisouth Koreafounded In 2010The Company Specializes In Developing Rna Interferencernaitherapeutics Aimed At Down Regulating Disease Causing Genesthis Innovative Approach Targets Various Diseases With Significant Unmet Medical Needs The Company Focuses On Research And Development Services Centered Around Rnai Technologyolix Collaborates With Several Partnersincluding Hansoh Pharmaceuticalsthe Korea Institute Of Technologyand The University Of Virginiato Advance Its Therapeutic Programsits Product Pipeline Includes Treatments For Conditions Such As Skin Scarsandrogenic Alopeciaage Related Macular Degenerationmetabolic Dysfunction Associated Steatohepatitishepatitisand Subretinal Fibrosis
No conferences found for this company.
| Company Name | Olix Pharmaceuticals Inc |
| Country |
South Korea
|
| Address | N/A |
| Telephone | N/A |
| N/A |
